Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement

This purpose of this study is to examine the placement of proton spots during pencil beam scanning proton therapy for low and intermediate risk prostate cancer. The researchers will test a unique technique called "Spot Delete" to control the placement of spots during treatment planning. They will also use a special computer model to study how the energy of the proton beam (linear energy transfer) is related to rectal and bladder side effects. The study involves creating a treatment plan based on a CT scan, which helps guide the proton beam in the body. The clinical team uses this CT scan to fi

Trial Details

NCT ID
NCT06200259
Phase
NA
Sponsor
Covenant Health Cancer Center
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Spot Delete planning for proton therapy
  • Traditional proton treatment planning system
Locations (sample)
  • Knoxville, Tennessee, United States|35.96064,-83.92074

Key Eligibility Criteria

  • Pathological proven diagnosis of prostatic adenocarcinoma
  • History and physical exam to establish clinical staging
  • Clinical stage T1-T2c (AJCC 7th edition)
  • Prostate specific antigen (PSA) \< 20 ng/mL

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →